Business March 20, 2015 Eli Lilly and China Innovent Biologics sign a 10-year cancer deal Elli Lilly has entered into a 10-year collaboration with Innovent Biologics (Suzhou, China) to develop, manufacture and commercialize three cancer drugs. Lilly will contribute its cMet monoclonal antibody and Innovent will contribute its CD 20 monoclonal antibody targeting protein and […]

Acquisitions /mergers/joint-ventures March 16, 2015 Counterbids for Salix: Valeant comes out as the winner In your previous newsweek we had indicated that “the bid for Salix could end up in a tough bidding war”. This already seems to be over with the new offer from Valeant. Endo’s last week proposal offered $175 per share, a […]

We wish to congratulate the EBD Group as well as Sanofi, the main sponsor, with the support of the BioCluster Medicen Paris Region, for a very well organized BIO-Europe Spring 2015 conference and for bringing the biopharmaceutical innovation community to Paris for the first time. Acquisitions /mergers/joint-ventures March 6, 2015 Targacept and Catalyst Biosciences announce […]

  BIO-Europe Spring 2015, organized by the EBD Group, took place in Paris earlier this week, March 9-11. According to the organizers there was a record breaking attendance of about 2,500 delegates coming from 80 different countries and 1369 companies. The conference was structured around the usual format: – Presentations of 120 companies (large, midsize […]

Acquisitions /mergers/joint-ventures Feb 26, 2015 Biota Pharmaceuticals to acquire French Anaconda Pharma for approximatively $47 million Biota Pharmaceuticals (Atlanta, USA) announced that it has entered into a definitive agreement to acquire Anaconda Pharma, a privately-held company based in Villejuif, Paris, France. Anaconda’s is a spin-off of the Institut Pasteur. Its main asset consists of AP611074, […]

Jean-Claude Muller & Nathalie Accornero will be very glad to meet you at Bio-Europe to discuss about your specific needs in Marketing & Business developement and competitive intelligence.    Nathalie Accornero -operational Marketing & Business Development send us an e-mail if you have no already booked a meeting Business Development • Identify and qualify new […]

Rare Disease Day is held the last day of February each year and is the occasion to raise awareness for rare diseases.   Acquisitions /mergers/joint-ventures February 22, 2015 Valeant proposes $14.5 billion to acquire Salix Valeant Pharmaceuticals (Raleigh, NC, USA) agreed to pay $14.5 billion to purchase Salix Pharmaceuticals (Laval, Quebec, Canada).The deal, which gives […]